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The Editorial on the Research Topic
Golgi Pathology in Neurodegenerative Diseases
The Golgi apparatus is a central organelle that lies at the heart of the secretory pathway sustaining
the delivery of proteins from their site of synthesis in the endoplasmic reticulum to their final
destination, the extracellular medium, the plasma membrane, and the endo-lysosomal system. It
ensures post-translational protein modifications such as glycosylation and proteolytic cleavage and
processing and acts as a sorting device including to neuronal axons and dendrites (Horton and
Ehlers, 2003; Ye et al., 2007).
The mammalian Golgi apparatus was first described by Camillo Golgi in 1998 as “apparato
reticolare interno,” “a fine and elegant network within the cell body . . . completely internal in the
nerve cells” (Golgi, 1898a,b). This large reticulum comprises stacks of flattened membrane bound
compartments called cisternae which are laterally linked to form the so-called Golgi ribbon.
Structural and functional alterations of the Golgi apparatus, which are here collectively
termed Golgi pathology, are now recognized as a constant pathological hallmark of various
neurodegenerative diseases including amyotrophic lateral sclerosis (ALS), Parkinson, Alzheimer,
Huntington, and prion diseases (Fan et al., 2008). In ALS, structural Golgi alterations have been
revealed by the pioneering work of Gonatas and colleagues (Mourelatos et al., 1990; Gonatas et al.,
1992; Fujita et al., 2002). They manifest as fragmentation—transformation of the Golgi ribbon
into disconnected stacks, cisternae, tubules and vesicles, and as atrophy—loss of Golgi membrane
material.
These morphological changes are often accompanied by functional Golgi alterations, such as
those affecting the anterograde and retrograde transport in the early secretory pathway, both in
cellular models of Parkinson (Cooper et al., 2006; Cho et al., 2014), Huntington (Caviston et al.,
2007; Pardo et al., 2010), and Alzheimer (Annaert et al., 1999; Joshi et al., 2014) diseases as well as
in ALS (Stieber et al., 2004; Soo et al., 2015).
At least in ALS, Golgi pathology manifests as an early pre-clinical feature in degenerating
neurons both in affected patients and in animal models (Mourelatos et al., 1996), suggesting that it
may be relevant to the disease process instead of just representing an epiphenomenon. Yet, neither
the molecular mechanisms underlying the changes in the functional organization of the Golgi
apparatus nor their precise relevance to neurodegeneration have yet been completely elucidated.
These important questions got a new boost by the discovery of mutations in genes encoding
Golgi-related proteins as direct causes of neurodegeneration. For instance, mutations inOptineurin
(Maruyama et al., 2010), VPS54/wobbler (Schmitt-John et al., 2005), and TBCE/pmn (Martin
et al., 2002) have been identified in ALS and related motor neuron diseases. Furthermore,
mutations in the Parkinson disease-associated proteins α-Synuclein (Cooper et al., 2006;
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Thayanidhi et al., 2010), LRRK2 (Lin et al., 2009; Cho et al.,
2014), Parkin (Shimura et al., 1999; Kubo et al., 2001), and VPS35
(McGough et al., 2014; Zavodszky et al., 2014; Malik et al., 2015)
have been shown to affect Golgi structure or transport processes
to and from the Golgi.
Furthermore, the recognition of Golgi-derived microtubules
and their specific functions, the better understanding of Golgi
transport processes, the recognition of the Golgi apparatus as
a sensor of cellular stress and as trigger of Golgi-specific cell
death pathways provide new hints to the molecular mechanisms
underlying Golgi pathology.
To cover these emerging themes, this Frontiers Research
Topic is organized as follows. The issue starts with a summary on
Golgi functional organization in neurons (Valenzuela and Perez)
and the relation of this organelle with microtubules (Sanders and
Kaverina).
This is followed by pathological, genetic, and mechanistic
descriptions of the major neurodegenerative diseases including
Parkinson disease (Wang and Hay), Alzheimer disease by
Wang and colleagues (Joshi et al.) and ALS by Atkin and
colleagues (Sundaramoorthy et al.). The Research topic then
focuses on Golgi fragmentation brought about by defects in
vesicle biogenesis and dynamics to and through the Golgi by
Lupashin and colleagues (Climer et al.) and by Schmitt-John,
including those caused by defects in Golgi-derived microtubules
in ALS (Haase and Rabouille) and microtubule-dependent
motors in proximal SMA (Jaarsma and Hoogenraad; Wirth and
Martinez-Carrera).
The third part of this issue starts by posing the hypothesis of
Farhan and colleagues that cellular stress can be the cause of Golgi
fragmentation, which in turn amplifies cellular stress and leads
to neurodegeneration (Alvarez-Miranda et al.). This is argued by
reviews on the effect of DNA damage on the Golgi by Field and
colleagues (Buschman et al.) and on the role of the Golgi as a cell
death trigger (Machamer).
Future studies on Golgi pathology in neurodegenerative
diseases will continue to benefit not only from conceptual
advances but also from new technical developements that have
been gigantic since Golgi’s original description of the black
reaction (tissue hardening with potassium dichromate and cell
staining by silver impregnation) (Mazzarello et al., 2009).
Electron microscopy has been used to unravel Golgi
fragmentation (Mourelatos et al., 1996) and in particular the
Golgi fragmentation into tubules and vesicles observed in
degenerating motor neurons (Bellouze et al., 2014), and its
resolution may be further improved in tissues prepared by high
pressure freezing (Walther et al., 2013). 3D reconstructions of the
Golgi and its microtubules (Marsh et al., 2001; Efimov et al., 2007)
may illustrate pathological changes in their intricate connections.
Golgi fragmentation can also be monitored by live imaging
(Altan-Bonnet et al., 2006), and super resolution microscopy
(Betzig et al., 2006; Lippincott-Schwartz and Manley, 2009) may
help refining the process. Last, system biology approches may
shed light on new pathways connecting Golgi fragmentation
to neurodegeneration by identifying novel gene networks
(Alvarez-Miranda et al.).
However, this field faces further challenges. It will be crucial to
determine whether Golgi pathology is contributory, causative or
homeostatic in neurodegeneration. In particular, it is important
to understand whether Golgi alterations are linked to axonal
degeneration and synapse loss or dysfunction.
It will also be crucial to analyze whether Golgi pathology
in each neurodegenerative disease is restricted to the neuron
types that are specifically affected, i.e., motor neurons in ALS,
dopaminergic neurons in PD, striatal neurons in Huntington. If
so, what may be the corresponding mechanisms of vulnerability
and resistance?
Furthermore, we will need to determine whether Golgi
alterations in degenerating neurons impact on the function
of their non-neuronal cellular neighbors, including astrocytes,
microglia and Schwann cells. Can this provide a potential
explanation for the non-cell autonomous disease spread observed
in numerous neurodegenerative diseases?
Finally and most importantly, can our burgeoning
knowledge on the molecular mechanisms of Golgi pathology
in neurodegenerative diseases be translated into earlier disease
diagnosis and new therapies for these severe and hitherto
untreatable disorders?
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